INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 18 filers reported holding INNATE PHARMA S A in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $124,000 | – | 20,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 146 | $545 | 0.00% |
| CITIGROUP INC | 54 | $201 | 0.00% |
| Optiver Holding B.V. | 105,534 | $394,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 71,684 | $267 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,315 | $49,665 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,954 | $11 | 0.00% |
| MORGAN STANLEY | 49,367 | $184,138 | 0.00% |
| ROYAL BANK OF CANADA | 125 | $0 | 0.00% |
| Steward Partners Investment Advisory, LLC | 500 | $1,865 | 0.00% |